Back to search
FDAFDA · Food and drugs·Recall number D-0824-2020

Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceutical Associates, Inc. Greenville, SC 29605. NDC 0121-0810-16

Published February 5, 2020 · Recall initiated: January 14, 2020

Summary

FDA records drug Class II recall D-0824-2020, published February 5, 2020 and initiated January 14, 2020. Recalling firm: Pharmaceutical Associates Inc; Status: Terminated; Reported quantity: 6288 16 oz bottles; Lot: Lots: BB70, BB71 Exp. May 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent: Out of specification for assay at the 12-month time point.

What to do

Voluntary: Firm initiated · Letter

Get an email if NYSTATIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NYSTATIN
Manufacturer
Pharmaceutical Associates Inc
Distributor
Distributed Nationwide in the US
UPC
0301210810022
Lot
Lots: BB70, BB71 Exp. May 2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceutical Associates, Inc. Greenville, SC 29605. NDC 0121-0810-16 recalled?

Yes. FDA published recall D-0824-2020 on February 5, 2020. Reported hazard: Subpotent: Out of specification for assay at the 12-month time point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NYSTATIN. UPC: 0301210810022.